D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
CHRS holding history
Coherus Oncology, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CHRS overviewAll 13F holders of CHRSFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −127,610−100.0% | Sold out | Holders |
| Q4 2023 | 127,610 | $424.9K | <0.1% | −578,798−81.9% | Reduced | Holders |
| Q3 2023 | 706,408 | $2.64M | <0.1% | −430,740−37.9% | Reduced | Holders |
| Q2 2023 | 1,137,148 | $4.86M | <0.1% | +138,770+13.9% | Added | Holders |
| Q1 2023 | 998,378 | $6.83M | <0.1% | +278,552+38.7% | Added | Holders |
| Q4 2022 | 719,826 | $5.70M | <0.1% | +124,282+20.9% | Added | Holders |
| Q3 2022 | 595,544 | $5.72M | <0.1% | +48,879+8.9% | Added | Holders |
| Q2 2022 | 546,665 | $3.96M | <0.1% | +180,878+49.4% | Added | Holders |
| Q1 2022 | 365,787 | $4.72M | <0.1% | +270,122+282.4% | Added | Holders |
| Q4 2021 | 95,665 | $1.53M | <0.1% | +50,998+114.2% | Added | Holders |
| Q3 2021 | 44,667 | $718.0K | <0.1% | −50,195−52.9% | Reduced | Holders |
| Q2 2021 | 94,862 | $1.31M | <0.1% | −174,771−64.8% | Reduced | Holders |
| Q1 2021 | 269,633 | $3.94M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.